Drug: LEVOFLOXACIN. Injury: Neuropathy peripheral Quarter: 2016Q3
Total Records: 58 Number of Pages: 3
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 126743711 | LEVOFLOXACIN. | Neuropathy peripheral | TEVA | 28.00 YR | F | 0 | 20160822 | US |
| 126823041 | LEVOFLOXACIN. | Neuropathy peripheral | BAYER | 0.00 | F | 0 | 20160824 | US |
| 126944071 | LEVOFLOXACIN. | Neuropathy peripheral | JANSSEN | 55.81 YR | F | 54 KG | 20160829 | US |
| 127150402 | LEVOFLOXACIN. | Neuropathy peripheral | JANSSEN | 0.00 | F | 0 | 20160926 | US |
| 127173951 | LEVOFLOXACIN. | Neuropathy peripheral | FDA-CTU | 43.00 YR | F | 53 KG | 20160906 | US |
| 127198551 | LEVOFLOXACIN. | Neuropathy peripheral | JANSSEN | 44.33 YR | F | 91 KG | 20160907 | US |
| 127198861 | LEVOFLOXACIN. | Neuropathy peripheral | JANSSEN | 57.48 YR | F | 101 KG | 20160907 | US |
| 127199281 | LEVOFLOXACIN. | Neuropathy peripheral | JANSSEN | 0.00 | F | 106 KG | 20160907 | US |
| 127199411 | LEVOFLOXACIN. | Neuropathy peripheral | JANSSEN | 63.06 YR | M | 0 | 20160907 | US |
| 127199421 | LEVOFLOXACIN. | Neuropathy peripheral | JANSSEN | 0.00 | M | 118 KG | 20160907 | US |
| 127199451 | LEVOFLOXACIN. | Neuropathy peripheral | JANSSEN | 0.00 | M | 0 | 20160907 | US |
| 127199481 | LEVOFLOXACIN. | Neuropathy peripheral | JANSSEN | 35.76 YR | M | 0 | 20160907 | US |
| 127199531 | LEVOFLOXACIN. | Neuropathy peripheral | JANSSEN | 62.92 YR | F | 0 | 20160907 | US |
| 127199581 | LEVOFLOXACIN. | Neuropathy peripheral | JANSSEN | 0.00 | M | 0 | 20160907 | US |
| 127199611 | LEVOFLOXACIN. | Neuropathy peripheral | JANSSEN | 50.53 YR | F | 0 | 20160907 | US |
| 127199631 | LEVOFLOXACIN. | Neuropathy peripheral | JANSSEN | 0.00 | F | 0 | 20160907 | US |
| 127199641 | LEVOFLOXACIN. | Neuropathy peripheral | JANSSEN | 0.00 | F | 0 | 20160907 | US |
| 127199701 | LEVOFLOXACIN. | Neuropathy peripheral | JANSSEN | 0.00 | F | 0 | 20160907 | US |
Total Records: 58 Number of Pages: 3